Systimmune, Inc.

Baili-bio (chengdu) Pharmaceutical Co., Ltd.

Jonathan K Fallen

Brian Robert Kovacevich

Zeren Gao

Blair R Renshaw

Yi Zhu

Dong Xia

Phil Tan

Jeffrey B Adamo

Anne E Jensen

The application provides the anti-PD-L1 monoclonal antibodies, antigen binding portions thereof, therapeutic compositions thereof and/or nucleic acid encoding the same, and their use to upregulate the function of T-cells to enhance cell-mediated immune responses in the treatment of cancer and other T-cell dysfunctional disorders.

Anti-PD-L1 antibodies and methods of making and using thereof

The application provides anti-PD-1 monoclonal antibodies, antigen binding portions thereof, therapeutic compositions thereof and/or nucleic acid encoding the same, and their use to upregulate the function of T-cells to enhance cell-mediated immune responses in the treatment of cancer and other T-cell dysfunctional disorders.

Anti-PD-1 antibodies and methods of making and using thereof

Growing community of inventors

Quincy, MA, United States of America

Jonathan K Fallen